- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Simcere Pharmaceutical Group
+ Add to WatchlistVV5:GR
7.155 EUR 0.033 0.46%As of 02:45:53 ET on 05/23/2013.
Snapshot for Simcere Pharmaceutical Group (VV5)
| Open: | 7.153 | Day's Range: | 7.153 - 7.155 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 7.122 | 52wk Range: | 5.542 - 7.230 | 1-Yr Rtn: | +6.57% |
Key Statistics for VV5
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 22.6569 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (CNY) (ttm) | - |
| Est. EPS (CNY) (12/2013) | 2.5010 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for VV5
Company Profile & Key Executives for VV5
Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.
| Hongquan LiuChief Executive Officer | Peng WangChief Scientific Officer |
| Jindong ZhouExecutive Vice President | Xiaojin YinSenior VP:Research & Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
VV5 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page